Regeneron Pharmaceuticals Revenue 2010-2024 | REGN

Regeneron Pharmaceuticals revenue for the twelve months ending September 30, 2024 was $13.847B, a 5.72% increase year-over-year.

  • Regeneron Pharmaceuticals annual revenue for 2023 was $13.117B, a 7.76% increase from 2022.
  • Regeneron Pharmaceuticals annual revenue for 2022 was $12.173B, a 24.26% decline from 2021.
  • Regeneron Pharmaceuticals annual revenue for 2021 was $16.072B, a 89.14% increase from 2020.

Regeneron Pharmaceuticals Revenue 2010-2024 | REGN

  • Regeneron Pharmaceuticals annual revenue for 2023 was $13.117B, a 7.76% increase from 2022.
  • Regeneron Pharmaceuticals annual revenue for 2022 was $12.173B, a 24.26% decline from 2021.
  • Regeneron Pharmaceuticals annual revenue for 2021 was $16.072B, a 89.14% increase from 2020.